Antaros Medical is at the American Diabetes Association’s 83rd Scientific Sessions presenting new repeatability data on using whole-body Positron Emission Tomography (PET) / Magnetic Resonance Imaging (MRI) to assess Fatty Acid Uptake (FAU). Iina Laitinen (Senior Director PET Imaging @ Antaros Medical) will present the first results of a study conducted in collaboration with Eli Lilly and Company, Turku PET Centre, and Clinical Research Services Turku – CRST Oy.
Type 2 diabetes (T2D) is a global health problem on the rise, and changes in fatty acid metabolism are an important component of its pathogenesis. Fatty acid uptake in tissues such as skeletal muscle, subcutaneous (SAT) and visceral adipose tissue (VAT), myocardium and the brain can be measured using PET imaging with the 18F-FTHA radiotracer. You can read more about using PET in clinical metabolic research on our blog.
This study assessed the repeatability of the tissue-specific FAU assessments from a novel whole-body PET/MRI imaging method in people with obesity with and without T2D, in both fasted and postprandial conditions.
The American Diabetes Association (ADA)‘s Annual Scientific Sessions is the world’s largest diabetes meeting, and this year will take place from June 23-26 in San Diego, California as well as virtually.
Abstract title: Assessment of Fatty Acid Uptake by PET/MRI Imaging Under Fasting and Postprandial Conditions: A Repeatability Study in People with T2DM and Obesity
Abstract number: #2023-A-2285-Diabetes
Poster presentation number: 1611-P
Authors: Laitinen I, Ekström S, Haraldsson H, Pierrou S, Kalliokoski K, Kiugel M, Scheinin M, Southekal S, Lu M, Coskun T, Milicevic Z, Johansson L, Nuutila P
Poster presentation in Integrated Physiology – Macronutrient Metabolism and Food Intake session, June 25 at 11:30-12:30 PDT.
Find the Final Program here.